|
Clinical chemists at WHX
Labs urged to lead
data-driven future of
healthcare
(DUBAI)
- A leading regional
healthcare expert opened the
Clinical Chemistry track
today at
WHX Labs at Dubai World
Trade Center (DWTC), urging
laboratory professionals to
evolve to meet the demands
of an increasingly
data-driven health
landscape.
During a
session titled “Smart Labs,
smart patients: Reinventing
clinical chemistry for the
future”, Riad
Bayoumi, Professor and Head
of Clinical Chemistry at
Mohammed Bin Rashid
University of Medicine and
Health Sciences,
outlined how Artificial
Intelligence (AI),
continuous patient
monitoring, and integrated
data systems are redefining
the role of clinical
chemistry within modern
hospitals.
Addressing the audience,
Bayoumi said,
“Can we move away from being
a service department to a
clinical intelligence engine
for medicine? Yes, we can.
Within our capacity as
clinical biochemists, we can
really be the champions of
an intelligent engine in
medicine.”
Professor
Bayoumi highlighted how
traditional laboratory
testing has historically
relied on isolated
measurements - or
“snapshots” - rather than
continuous physiological
data. With technologies such
as AI and continuous
monitoring now gaining
traction, he argued that
clinical chemistry is
uniquely positioned to
underpin future
decision-support systems.
“If you look at the lab,
we are sitting on 75% of the
information that will help a
clinician to make a
decision. Therefore, the
position of a clinical
chemist should be at the
centre of decision making
within a hospital – not
simply someone who is
offering figures and numbers
for a clinician to think
about.”
Professor
Bayoumi emphasized that
laboratories are uniquely
positioned to serve as the
foundation of AI-driven
decision support systems.
Clinical chemistry already
operates within highly
automated and integrated
workflows, generating
consistent quantitative
outputs, precisely the type
of structured data required
for advanced machine
learning and predictive
modelling.
The
session addressed the
growing influence of
external AI teams, expanding
IT departments, and
technology providers
entering the healthcare
space. Professor Bayoumi
cautioned that laboratories
must actively engage with
this technological shift to
maintain their strategic
role within clinical
decision-making ecosystems.
He also referenced the
growing role of digital
twins in healthcare, where
virtual patient models are
used to simulate clinical
scenarios, anticipate risks,
and personalize treatment
strategies. Such approaches,
he explained, rely heavily
on time-series quantitative
data, an area where clinical
chemistry already plays a
foundational role.
Tom Coleman,
Portfolio Director, Informa
Markets, commented:
“The conversations taking
place within the Clinical
Chemistry track at WHX Labs
today highlight a clear
shift in how laboratories
are perceived within
healthcare. As new
technologies develop,
clinical chemistry is
increasingly positioned as a
cornerstone of data-driven
medicine.”
The
Clinical Chemistry track
forms one of nine
CME-accredited conference
tracks at WHX Labs,
convening international
specialists to explore
advances in testing
methodologies, quality
assurance, and laboratory
technologies.
Clinical Chemistry underpins
a significant proportion of
modern diagnostics, guiding
medical decisions across
every stage of patient care,
from early detection and
diagnosis to treatment
monitoring and disease
management. Against a
backdrop of rapid
technological advancement,
the discussions at today’s
Clinical Chemistry track
have centered on how
laboratories can translate
innovation into routine
clinical practice, while
maintaining accuracy,
efficiency, and clinical
relevance.
Across
the exhibition floor at WHX
Labs, these themes are
reflected in the
technologies and solutions
showcased by global
exhibitors. AxisOne is
presenting its AI-powered
Global R&D Platform,
designed to combine
laboratory discovery,
predictive timelines, and
performance benchmarking
into a single integrated
workflow for research and
diagnostics teams.
Meanwhile, Genes2Me is
demonstrating its end-to-end
automated molecular
diagnostics systems,
supporting laboratories in
delivering accurate,
scalable, and cost-effective
advanced testing solutions.
Thursday’s program
at WHX Labs will focus on
the AMR Leaders’ Summit
alongside the Molecular
Diagnostics and
Histopathology tracks, as
the 25th Annual Laboratory
Management and Medicine
Congress continues. WHX Labs
runs until 13 February at
DWTC and is co-timed with
WHX, held at Dubai
Exhibition Center, to form
the world’s largest
healthcare event.
PRINT
THIS ARTICLE
|
